Brain specific delivery of pegylated indinavir submicron lipid emulsions

European Journal of Pharmaceutical Sciences

Volumn 42, Issue 4, 2011, Pages 423-432

  Kandadi, Prabhakar ^a   Syed, Muzammil Afzal ^a   Goparaboina, Surendar ^a   Veerabrahma, Kishan ^a  

^a University College of Pharmaceutical Sciences   (India)

Author keywords

Brain specific delivery; DPPE PEG 5000; DSPE PEG 2000; Pegylated submicron lipid emulsions

Indexed keywords

INDINAVIR; LIPID EMULSION; PEGYLATED INDINAVIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CHRONIC DISEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SPECIFICITY; ULTRASOUND; ZETA POTENTIAL;

ANIMALS; BRAIN; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; FAT EMULSIONS, INTRAVENOUS; HIV PROTEASE INHIBITORS; INDINAVIR; LIPIDS; MALE; MICE; NANOPARTICLES; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; POLYETHYLENE GLYCOLS; SONICATION; SOYBEAN OIL; TISSUE DISTRIBUTION;

EID: 79952281793     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.01.008     Document Type: Article

References (43)

1. E.P. Acosta, K. Henry, L. Baken, L.M. Page, and C.V. Fletcher Indinavir concentrations and antiviral effect Pharmacotherapy 19 1999 708 712 (Pubitemid 29277970)
2. H.S. Alfred P-glycoprotein, a gatekeeper in the blood-brain barrier Adv. Drug Deliv. Rev. 36 1999 179 194
3. C. Allen, N. Dos Santos, R. Gallagher, G.N. Chiu, Y. Shu, W.M. Li, S.A. Johnstone, A.S. Janoff, L.D. Mayer, M.S. Webb, and M.B. Bally Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) Biosci. Rep. 22 2002 225 250 (Pubitemid 35222733)
4. A.S. Andrew Protease inhibitors may reverse AIDS dementia JAMA Med. News Perspect. 279 1998 419
5. V.D. Awasthi, D. Garcia, B.A. Goins, and W.T. Phillips Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits Int. J. Pharmaceut. 253 2003 121 132 (Pubitemid 36204032)
6. C.J. Bachmeier, T.J. Spitzenberger, W.F. Elmquist, and D.W. Miller Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier Pharm. Res. 22 2005 1259 1268 (PubMed: 16078135) (Pubitemid 41176029)
7. G. Blume, and G. Cevc Molecular mechanism of the lipid vesicle longevity in vivo Biochim. Biophys. Acta 1146 1993 157 168 (Pubitemid 23084758)
8. M.E. Brewster, W. Anderson, and N. Bodor Brain, blood and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits J. Pharm. Sci. 80 1991 843 846
9. ® Eur. J. Pharm. Biopharm. 49 2 2000 143 149 (Pubitemid 30126062)
10. E.F. Choo, B. Leake, C. Wandel, H. Imamura, A.J. Wood, G.R. Wilkinson, and R.B. Kim Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes Drug Metab. Dispos. 28 2000 655 660 (PubMed: 10820137) (Pubitemid 30390404)
11. J.J. Eron HIV-protease inhibitors Clin. Infect. Dis. 30 Suppl. 2 2000 S160 S170
12. M.J. Groves, and C.J. Herman The redistribution of bulk aqueous phase phospholipids during thermal stressing of phospholipid-stabilized emulsions J. Pharm. Pharmacol. 45 1993 592 596 (Pubitemid 23226746)
13. R.M. Gulick, J.W. Mellors, D. Havlir, J.J. Eron, C. Gonzalez, D. McMahon, D.D. Richman, F.T. Valentine, L. Jonas, A. Meibohm, E.A. Emini, and J.A. Chodakewitz Treatment with indinavir, zidovudine, and lamivudine in adults with human immuno deficiency virus infection and prior antiretroviral therapy New Engl. J. Med. 337 1997 734 739 (Pubitemid 27417972)
14. T. Handa, Y. Eguchi, and K. Miyajima Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglyceride/ phosphatidylcholine emulsions in rats Pharm. Res. 11 1994 1283 1287 (Pubitemid 24287407)
15. T. Handa, H. Saito, and K. Miyajima Phospholipid monolayers at the triolein saline Interface: production of microemulsion particles and conversion of monolayers to bilayers Biochemistry 29 11 1990 2884 2890 (Pubitemid 20122625)
16. M. Hultin, C. Carneheim, K. Rosenqvist, and T. Olivecrona Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons J. Lipid Res. 36 1995 2174 2184
17. R. Igarashi, M. Takenaga, and T. Matsuda Distribution of the lipid microsphere preparations Adv. Drug Deliv. Rev. 20 1996 147 154
18. F. Ishii, I. Sasaki, and H. Ogata Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions J. Pharm. Pharmacol. 42 1990 513 515 (Pubitemid 20301493)
19. R. Joanna, G. Suzanne, M.D.N. Khalid, D. Pascal, C. Allen, and J.C. Leroux Long-circulating poly(ethylene glycol)-coated emulsions to target solid tumors Eur. J. Pharm. Biopharm. 67 2007 329 338 (Pubitemid 47211921)
20. R.B. Kim, M.F. Fromm, C. Wandel, B. Leake, A.J. Wood, D.M. Roden, and G.R. Wilkinson The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J. Clin. Invest. 101 1998 289 294 (Pubitemid 28067324)
21. S. Klang, and S. Benita S. Benita, Submicron Emulsions in Drug Delivery Hardwood 1998 Academic Publishers Amsterdam
22. J. Kreuter Nanoparticles systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81 (Pubitemid 32209233)
23. G. Krishna, G.C. Wood, and B.B. Sheth Improving emulsification efficacy of lecithin by formulation design. I. Effect of adding secondary surfactant PDA J. Pharm. Sci. Technol. 52 1998 331 336 (Pubitemid 29088983)
24. S.A. Lipton Neuronal injury associated with HIV-1: approaches to treatment Annu. Rev. Pharmacol. Toxicol. 38 1998 159 177 (Pubitemid 28231492)
25. B.B. Lundberg Preparation of drug-carrier emulsions stabilized with phosphatidyl choline-surfactant mixtures J. Pharm. Sci. 83 1994 72 75
26. B.B. Lundberg, B.C. Mortimer, and T.G. Redgrave Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time Int. J Pharm. 134 1996 119 127 (Pubitemid 26001133)
27. R.C. Maranhao, A.M. Tercyak, and T.G. Redgrave Effects of cholesterol content on the metabolism of protein free emulsion models of lipoproteins Biochim. Biophys. Acta 875 1986 247 255 (Pubitemid 16149047)
28. M. Hamidi Role of P-glycoprotein in tissue uptake of indinavir in rat Life Sci. 79 2006 991 998 (Pubitemid 44061876)
29. M. Hamidi Simple and sensitive high-performance liquid chromatography method for the quantitation of indinavir in rat plasma and central nervous system J. Sep. Sci. 29 2006 620 627
30. S. Meyer, S. Berrut, T.I.J. Goodenough, V.S. Rajendram, V.J. Pinfield, and M.J.W. Povey A comparative study of ultrasound and laser light diffraction techniques for particle size determination in dairy beverages Meas. Sci. Technol. 17 2006 289 297 (Pubitemid 43131586)
31. D. Papahadjopoulos, T.M. Allen, A. Gabizon, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, and C. Redemann Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U.S.A. 24 1991 11460 11464 (Pubitemid 21916061)
32. R.R. Patlolla, and V. Vobalaboina Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion J. Pharm. Sci. 94 2 2005 437 445 (Pubitemid 40293338)
33. G. Pialoux, S. Fournier, A. Moulignier, J.D. Poveda, F. Clavel, and B. Dupont Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir AIDS 11 1997 1302 1303 (Pubitemid 27298104)
34. T.G. Redgrave, V. Rakic, B.C. Mortimer, and J.C.L. Mamo Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with lipid emulsions in rats Biochim. Biophys. Acta 1126 1992 65 72
35. S.C. Semple, R. Leone, J. Wang, E.C. Leng, K.S. Klimuk, L.M. Eisenhardt, Z.N. Yuan, K. Edwards, N. Maurer, M.J. Hope, P.R. Cullis, and Q.F. Ahkong Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity J. Pharm. Sci. 94 2005 1024 1038 (Pubitemid 40780769)
36. J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol) coated vesicles Biochim. Biophys. Acta 1062 1991 77 82
37. Q. Shen, Y. Lin, T. Handa, M. Doi, M. Sugie, K. Wakayama, N. Okada, T. Fujita, and A. Yamamoto Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies Int. J. Pharm. 313 2006 49 56
38. E. Shotton, and S.S. Davis A note on the stability of emulsion on high dilution J. Pharm. Pharmacol. 20 11 1968 825 829
39. K. Takino, Y. Konishi, M. Takakura, and M. Hashida Long circulating emulsion carrier systems for highly lipophilic drugs Biol. Pharm. Bull. 17 1994 121 125 (Pubitemid 24056997)
40. E. Varshika, K. Prabhakar, and V. Kishan Preparation, characterization and in vivo pharmacodynamic evaluation of parenteral diclofenac submicron lipid emulsions PDA J. Pharm. Sci. Technol. 63 2 2009 1368 1372
41. V. Venkateshwarlu, and R.R. Patlolla Lipid microspheres as drug delivery systems Ind. J. Pharm. Sci. 63 2001 450 458
42. C. Washington, A. Chawla, N. Christy, and S.S. Davis The electrokinetic properties of phospholipid stabilized fat emulsions Int. J. Pharmaceut. 54 1989 191 197
43. G.P. Zara, R. Cavali, A. Bargoni, A. Fundaro, D. Vighetto, and M.R. Gasco Intravenous administration to rabbits non-stealth and stealth doxorubicin loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and tissue distribution of doxorubicin in brain and other tissues J. Drug Target 10 4 2002 327 335 (Pubitemid 34746314)